Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 69 of 202 for:    strength | Norway

Pain After Cesarean Sectio.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03730246
Recruitment Status : Recruiting
First Posted : November 5, 2018
Last Update Posted : November 5, 2018
Sponsor:
Information provided by (Responsible Party):
Johan C Ræder, Oslo University Hospital

Brief Summary:
To study the strength of postoperative pain 0-24 hrs after elective cesarean sectio in spinal anaesthesia.

Condition or disease Intervention/treatment
Pain Analgesic Medication Procedure: cesarean sectio

Layout table for study information
Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Postoperative Pain 0-24 hr After Cesarean Sectio
Actual Study Start Date : August 1, 2018
Estimated Primary Completion Date : December 31, 2018
Estimated Study Completion Date : July 31, 2019

Intervention Details:
  • Procedure: cesarean sectio
    consecutive parturients due for cesarean sectio


Primary Outcome Measures :
  1. postoperative pain strenght [ Time Frame: 0-24 hrs ]
    NRS pain


Secondary Outcome Measures :
  1. rescue drug needed [ Time Frame: 0-24 hrs ]
    dose of rescue opioid drug



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 50 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
all patients due for cesarean sectio are eligible
Criteria

Inclusion Criteria:

  • cesearean sectio

Exclusion Criteria:

  • none

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03730246


Locations
Layout table for location information
Norway
Dept of Anesthesiology, Oslo University Hospital, Ullevaal Recruiting
Oslo, Norway, 0407
Contact: Johan Raeder, PhD    004792249669    johan.rader@medisin.uio.no   
Sponsors and Collaborators
Oslo University Hospital

Layout table for additonal information
Responsible Party: Johan C Ræder, Professor, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT03730246     History of Changes
Other Study ID Numbers: Sectio.Pain.Jenny
First Posted: November 5, 2018    Key Record Dates
Last Update Posted: November 5, 2018
Last Verified: November 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No